Clinicians' preferences for adjuvant chemotherapy (ACT) in non-small-cell lung cancer (NSCLC): what makes it worthwhile?

Prunella Blinman, Sue-Anne McLachlan, Anna Nowak, Vlatka Duric, Gavin Wright, Michael Millward, Chris Brown, Xanthi Coskinas, Kwun Fong, Martin Stockler

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S581-S581
Number of pages1
JournalJournal of Thoracic Oncology
Issue number9
Publication statusPublished - Sept 2009

Cite this